Cancer following renal transplantation. Case report;Neoplasie e trapianto renale: Contributo casistico

Minerva Urologica e Nefrologica

Volumn 50, Issue 2, 1998, Pages 127-131

  Capocasale, E ^a,c   Bignardi, L ^b   Adorni, A ^a   D'Errico, G ^a   Viola, V ^a   Botta, G C ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b Cattedra di Nefrologia Medica   (Italy)

^c NONE   (Italy)

Author keywords

Immunosuppression adverse effects; Immunosuppressive agents; Kidney transplantation; Neoplasms etiology; Treatment outcome

Indexed keywords

ANTINEOPLASTIC AGENT; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; FEMALE; HUMAN; IMMUNOLOGY; KAPOSI SARCOMA; KIDNEY TRANSPLANTATION; KIDNEY TUMOR; MALE; MIDDLE AGED; NEOPLASM; POSTOPERATIVE COMPLICATION; RETROSPECTIVE STUDY; SKIN TUMOR;

ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY NEOPLASMS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASMS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SARCOMA, KAPOSI; SKIN NEOPLASMS;

EID: 0032092624     PISSN: 03932249     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Penn I The incidence of malignancies in transplant recipient. Transplant Proc 1975;7:323-6.
2. Kinlen U. Cancer as a risk in transplantation In: Touranaine IL, editor Transplantation and clinical immunology Risks factors in organ transplantation. Excepta Medica Symposia, Foundation Mérieux 12. Elsev Sci Publ 1985;87-95.
3. Penn I Cancers following cyclosporine therapy. Transplantation 1987;43.32-5.
4. Birkeland Sven A. et al. Cancer risk after renal transplantation in the Nordic Countries, 1964-1986 Int J Cancer 1995;60:183-9.
5. Penn I. Cancer is a long term hazard of immunosuppressive therapy. J Autoimmunity 1988;1:545-58
6. Wilkinson ALL, Smith JL, Hunsiker LG. Increased frequency of post transplant lymphomas in patients treated with cyclosporine, azathioprine and prednisone Transplantation 1989;47:293-6.
7. Shell A. G.R. In. XIV Report of the Australia and New Zealand Combined Dialysis and Transplant Registry (APS. Disney, ed), p 100.
8. Cockburn I. Assessment of the risk of malignancy and lymphomas developing in patients using Sandimmune. Transplant Proc 1987;19:1804-7
9. Frei U, Bode U et al. Malignancies under cyclosporine after kidney transplantation analysis of a 10-year period Transplant Proc 1993;25.1394-6.
10. Hauser AC, Derfler K, Smith F. Post-transplantation malignant disease in patient with analgesic nephropathy. Lancet 1990;1:58.
11. Penn I. The effect of Immunosuppression on pre-existing cancers. Transplantation 1993;55(4):742-7
12. Penn I Donor transmitted disease: cancer. Transplant Proc 1991,23(5):2629-31
13. Hoffmann HJ, Duffner PK Extraneural metastases of central nervous system tumors. Cancer 1985,56.1778-82.
14. Detry D, Detroz B, D'Silva M, Pirenne J, Defraigne JO, Meurisse M et al Misdiagnosed malignancy in transplanted organs. Transpl Int 1992;6:50-4
15. Penn I. Malignancy in transplanted organs Transpl Int 1993;6:1-3.
16. Berardinelli L, Costantino B, Vegeto A. Esperienza multicentrica su tumore e trapianto renale. Atti XXIII Congresso SITO Settembre 1995,151-62.
17. Alamartine E, Sabido O The low number of natural killer cells in renal transplant recipient with de novo malignancies. Transplantation 1992;54(3).569-71
18. Penn I Risk of cancer in the transplant patient. In: MW Flye, editor. Principles of organ transplantation. Philadelphia: Saunders, 1989
19. Penn I. Tumors arising in organ transplant recipients. Adv Cancer Res 1978;28:31-61.
20. Khaler AA, Suleiman M, Al-Hasani M, Silva T, Sartor F. Post-transplant Kaposi sarcoma: staging as a guide to therapy and prognosis Nephron 1988;48:165.
21. Shuttleworth D, Roberts E, Griffin PJA Renal transplantation and the skin. Lancet 1988;i:293-4.
22. Penn I. Tumors after renal and cardiac transplantation. Haematol Oncol Clin North Am 1993,7.2
23. Lanza RP, Cooper DCK, Cassidy MJSC, Wilkinson A, Howard K Malignancy following cardiac transplantation. JAMA 1983,29.1746.